478 related articles for article (PubMed ID: 12635136)
1. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
[TBL] [Abstract][Full Text] [Related]
3. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors.
Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T
J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145
[TBL] [Abstract][Full Text] [Related]
6. [Pathology of intraductal papillary-mucinous tumor of the pancreas].
Nobukawa B; Suda K; Yamasaki S; Takase M; Fukumura Y; Shiono S
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):439-42. PubMed ID: 12854489
[TBL] [Abstract][Full Text] [Related]
7. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
[TBL] [Abstract][Full Text] [Related]
8. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
9. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
[TBL] [Abstract][Full Text] [Related]
11. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
[TBL] [Abstract][Full Text] [Related]
12. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Tanaka M; Manabe T
Scand J Gastroenterol; 2004 Nov; 39(11):1159-65. PubMed ID: 15545177
[TBL] [Abstract][Full Text] [Related]
14. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
[TBL] [Abstract][Full Text] [Related]
15. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
[TBL] [Abstract][Full Text] [Related]
16. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous neoplasm.
Shi C; Hruban RH
Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
[TBL] [Abstract][Full Text] [Related]
18. Expression of laminin-5-gamma-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas.
Fukushima N; Sakamoto M; Hirohashi S
Mod Pathol; 2001 May; 14(5):404-9. PubMed ID: 11353049
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of precursors to pancreatic cancer.
Takaori K
J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
[TBL] [Abstract][Full Text] [Related]
20. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
Sanada Y; Kunita S; Yoshida K
Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]